Literature DB >> 32586676

Encephalitis Associated with COVID-19 Infection in an 11-Year-Old Child.

Gary N McAbee1, Yuri Brosgol2, Steven Pavlakis2, Rabia Agha2, Mohamed Gaffoor2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32586676      PMCID: PMC7180343          DOI: 10.1016/j.pediatrneurol.2020.04.013

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


× No keyword cloud information.
To the Editor, Neurological complications associated with COVID-19 infection are not well understood in children or adults. An adult with acute necrotizing encephalitis associated with COVID-19 and a child with acute disseminated encephalomyelitis and non-COVID coronavirus have been reported. The infection is typically mild in children, and no neurological complications were reported in the 171 children from Wuhan Children’s Hospital. In preliminary data from US cases, headache was the only neurological symptom. We describe an 11-year-old previously well child who presented with status epilepticus requiring four anticonvulsant medications and cerebrospinal fluid evidence for encephalitis (921 red cells, 16 white cells, 8% neutrophils [normal 0% to 6%] with protein of 97 [normal: 40 to 170 mg/dL], and glucose of 92 [normal: 20 to 100 mg/dL]). He had a two-day history of generalized weakness without respiratory symptoms or fever at home; emergency room temperature was 102.7°F. Head computed tomography was negative. Electroencephalography revealed frontal intermittent delta activity. Nasopharyngeal swab was positive for COVID-19 as well as rhinovirus/enterovirus but the latter was absent in cerebrospinal fluid polymerase chain reaction. Recovery without treatment was complete in six days. We believe this is the first child reported with COVID-19 viral encephalitis, and the condition was reversible. How coronavirus affects the brain is not known. This child’s findings suggest that direct brain infection may be possible. An autoimmune process may also be possible. The acuteness of our patient’s neurological manifestations coupled with the occurrence of fever and generalized systemic weakness mitigates against a postinfectious process. Because the virus binds the surface spike protein to the human angiotensin-converting enzyme 2 receptor (ACE-2) and ACE-2 is present in the brain vascular endothelium, a vascular process with clotting and infarction may also be possible, although this was not the mechanism in our patient.5, 6, 7 Although preliminary, we recommend screening children presenting with encephalitis for COVID-19 as infected patients require special precautions to prevent further spread.
  49 in total

1.  Neurological issues in COVID-19, summarized in verse.

Authors:  Meredith R Golomb
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-11       Impact factor: 2.136

2.  COVID-19-Induced Encephalitis: A Case Report of a Rare Presentation With a Prolonged Electroencephalogram.

Authors:  Mohammed A Miqdad; Saed Enabi; Mohammad Alshurem; Tariq Al-Musawi; Abdullah Alamri
Journal:  Cureus       Date:  2021-04-13

Review 3.  NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.

Authors:  Debashis Dutta; Jianuo Liu; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-06-15

Review 4.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

Review 5.  SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.

Authors:  Kiandokht Keyhanian; Raffaella Pizzolato Umeton; Babak Mohit; Vahid Davoudi; Fatemeh Hajighasemi; Mehdi Ghasemi
Journal:  J Neuroimmunol       Date:  2020-11-07       Impact factor: 3.478

Review 6.  Status epilepticus and COVID-19: A systematic review.

Authors:  Fedele Dono; Bruna Nucera; Jacopo Lanzone; Giacomo Evangelista; Fabrizio Rinaldi; Rino Speranza; Serena Troisi; Lorenzo Tinti; Mirella Russo; Martina Di Pietro; Marco Onofrj; Laura Bonanni; Giovanni Assenza; Catello Vollono; Francesca Anzellotti; Francesco Brigo
Journal:  Epilepsy Behav       Date:  2021-03-17       Impact factor: 3.337

7.  Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature.

Authors:  L Siracusa; A Cascio; S Giordano; A A Medaglia; G A Restivo; I Pirrone; G F Saia; F Collura; C Colomba
Journal:  Ital J Pediatr       Date:  2021-06-02       Impact factor: 2.638

Review 8.  Cerebrospinal fluid findings in patients with seizure in the setting of COVID-19: A review of the literature.

Authors:  Elizabeth Carroll; Kara R Melmed; Jennifer Frontera; Dimitris G Placantonakis; Steven Galetta; Laura Balcer; Ariane Lewis
Journal:  Seizure       Date:  2021-05-17       Impact factor: 3.414

9.  Fatal Pediatric COVID-19 Case With Seizures and Fulminant Cerebral Edema.

Authors:  Siddharth Ninan; Peyton Thompson; Timothy Gershon; Natalie Ford; William Mills; Valerie Jewells; Leigh Thorne; Katherine Saunders; Thomas Bouldin; Jason R Smedberg; Melissa B Miller; Eveline Wu; Alyssa Tilly; Jeremy Sites; Daniel Lercher; Katherine Clement; Tracie Walker; Paul Shea; Benny Joyner; Rebecca Smith
Journal:  Child Neurol Open       Date:  2021-06-14

Review 10.  Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.

Authors:  Saikat Dewanjee; Jayalakshmi Vallamkondu; Rajkumar Singh Kalra; Nagaprasad Puvvada; Ramesh Kandimalla; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-06-24       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.